DAWES KAREN A

Director at PDL BIOPHARMA, INC. · on record since Jun 16, 2006
Director at REPLIGEN CORP · on record since Sep 18, 2006
Chairperson of the Board at PDL BIOPHARMA, INC. · on record since Oct 5, 2007
Director at Assertio Therapeutics, Inc · on record since Apr 8, 2008
Director at GENAISSANCE PHARMACEUTICALS INC · on record since Oct 2, 2003
Director at Assertio Holdings, Inc. · on record since Dec 4, 2018
Director at Barinthus Biotherapeutics plc. · on record since Apr 29, 2021

Insider trading activity of DAWES KAREN A

Transactions on record: 237; since Oct 2, 2003

Open-market buys: 11; $128.6K

Open-market sells: 92; $17.7M

Companies traded: 6; last filing Sep 9, 2026

Figures computed from official regulatory filings — .

Companies where DAWES KAREN A has traded

Barinthus Biotherapeutics plc.12 tx · $28.9K · Sep 9, 2026
REPLIGEN CORP163 tx · $19.2M · May 18, 2026
Assertio Holdings, Inc.10 tx · $115.4K · May 11, 2020
Assertio Therapeutics, Inc20 tx · $63K · May 10, 2018
PDL BIOPHARMA, INC.25 tx · $30.5K · Apr 30, 2008
GENAISSANCE PHARMACEUTICALS INC7 tx · $50K · Oct 6, 2005

Track record of DAWES KAREN A

Statistical track record

Free account

Open-market buys: 11

Last buy: May 4, 2021

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of DAWES KAREN A

Co-insiders of DAWES KAREN A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-20,174	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-19,516	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-19,197	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-18,604	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	Other	-1,700	—	n/a (No price was disclosed in the filing)		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-34,328	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 18, 2026	AwardD (derivative)	2,239	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 18, 2026	Award	995	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Dec 18, 2025	Sell	-275	161.00 USD	$44.3K		SEC
Barinthus Biotherapeutics plc.Listing on record	Jun 11, 2025	AwardD (derivative)	20,174	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 19, 2025	Award	973	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 19, 2025	AwardD (derivative)	1,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Jun 14, 2024	Exercise	2,953	67.71 USD	$199.9K	Unusual size	SEC
REPLIGEN CORPListing on record	Jun 14, 2024	ExerciseD (derivative)	2,953	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 20, 2024	AwardD (derivative)	1,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 20, 2024	Award	803	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	May 14, 2024	AwardD (derivative)	19,516	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Feb 28, 2024	ExerciseD (derivative)	4,626	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Feb 28, 2024	Sell	-1,000	193.35 USD	$193.4K		SEC
REPLIGEN CORPListing on record	Feb 28, 2024	Exercise	4,626	42.07 USD	$194.6K	Unusual size	SEC
REPLIGEN CORPListing on record	Aug 30, 2023	Sell	-850	171.38 USD	$145.7K		SEC
REPLIGEN CORPListing on record	Aug 30, 2023	ExerciseD (derivative)	7,392	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Aug 30, 2023	Exercise	7,392	18.12 USD	$133.9K		SEC
REPLIGEN CORPListing on record	May 22, 2023	Award	798	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 22, 2023	AwardD (derivative)	1,730	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-20,174	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-19,516	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-19,197	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-18,604	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	Other	-1,700	—	n/a (No price was disclosed in the filing)		SEC
Barinthus Biotherapeutics plc.Listing on record	Sep 9, 2026	OtherD (derivative)	-34,328	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 18, 2026	AwardD (derivative)	2,239	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 18, 2026	Award	995	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Dec 18, 2025	Sell	-275	161.00 USD	$44.3K		SEC
Barinthus Biotherapeutics plc.Listing on record	Jun 11, 2025	AwardD (derivative)	20,174	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 19, 2025	Award	973	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 19, 2025	AwardD (derivative)	1,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Jun 14, 2024	Exercise	2,953	67.71 USD	$199.9K	Unusual size	SEC
REPLIGEN CORPListing on record	Jun 14, 2024	ExerciseD (derivative)	2,953	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 20, 2024	AwardD (derivative)	1,576	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 20, 2024	Award	803	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Barinthus Biotherapeutics plc.Listing on record	May 14, 2024	AwardD (derivative)	19,516	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Feb 28, 2024	ExerciseD (derivative)	4,626	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Feb 28, 2024	Sell	-1,000	193.35 USD	$193.4K		SEC
REPLIGEN CORPListing on record	Feb 28, 2024	Exercise	4,626	42.07 USD	$194.6K	Unusual size	SEC
REPLIGEN CORPListing on record	Aug 30, 2023	Sell	-850	171.38 USD	$145.7K		SEC
REPLIGEN CORPListing on record	Aug 30, 2023	ExerciseD (derivative)	7,392	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	Aug 30, 2023	Exercise	7,392	18.12 USD	$133.9K		SEC
REPLIGEN CORPListing on record	May 22, 2023	Award	798	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
REPLIGEN CORPListing on record	May 22, 2023	AwardD (derivative)	1,730	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC